SVB Wealth LLC Buys New Holdings in Teladoc Health, Inc. $TDOC

SVB Wealth LLC bought a new stake in shares of Teladoc Health, Inc. (NYSE:TDOC) in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor bought 4,624 shares of the health services provider’s stock, valued at approximately $37,000.

Several other institutional investors also recently bought and sold shares of the stock. Vanguard Group Inc. boosted its holdings in Teladoc Health by 7.0% during the 1st quarter. Vanguard Group Inc. now owns 19,752,338 shares of the health services provider’s stock valued at $157,229,000 after acquiring an additional 1,289,183 shares during the period. Point72 Asset Management L.P. boosted its holdings in Teladoc Health by 33.6% during the 4th quarter. Point72 Asset Management L.P. now owns 11,179,863 shares of the health services provider’s stock valued at $101,625,000 after acquiring an additional 2,813,568 shares during the period. Maple Rock Capital Partners Inc. boosted its holdings in Teladoc Health by 189.5% during the 4th quarter. Maple Rock Capital Partners Inc. now owns 3,561,000 shares of the health services provider’s stock valued at $32,369,000 after acquiring an additional 2,331,000 shares during the period. Dimensional Fund Advisors LP boosted its holdings in Teladoc Health by 0.3% during the 4th quarter. Dimensional Fund Advisors LP now owns 3,531,492 shares of the health services provider’s stock valued at $32,104,000 after acquiring an additional 8,890 shares during the period. Finally, Charles Schwab Investment Management Inc. boosted its holdings in Teladoc Health by 5.2% during the 1st quarter. Charles Schwab Investment Management Inc. now owns 2,571,673 shares of the health services provider’s stock valued at $20,471,000 after acquiring an additional 127,960 shares during the period. 76.82% of the stock is currently owned by hedge funds and other institutional investors.

Insider Activity

In related news, insider Fernando M. Rodrigues sold 4,174 shares of the firm’s stock in a transaction that occurred on Tuesday, June 3rd. The stock was sold at an average price of $6.91, for a total transaction of $28,842.34. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, insider Carlos Nueno sold 3,958 shares of the firm’s stock in a transaction that occurred on Monday, June 2nd. The shares were sold at an average price of $6.86, for a total value of $27,151.88. Following the transaction, the insider directly owned 17,645 shares of the company’s stock, valued at approximately $121,044.70. This trade represents a 18.32% decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 18,656 shares of company stock worth $128,189 in the last quarter. 0.58% of the stock is owned by company insiders.

Teladoc Health Trading Down 0.8%

TDOC opened at $7.75 on Thursday. The stock has a market cap of $1.37 billion, a PE ratio of -6.51 and a beta of 1.76. The company has a quick ratio of 2.58, a current ratio of 2.67 and a debt-to-equity ratio of 0.70. The business has a 50 day moving average of $7.77 and a 200-day moving average of $8.14. Teladoc Health, Inc. has a 52 week low of $6.35 and a 52 week high of $15.21.

Teladoc Health (NYSE:TDOC) last released its earnings results on Tuesday, July 29th. The health services provider reported ($0.19) EPS for the quarter, beating analysts’ consensus estimates of ($0.27) by $0.08. The company had revenue of $631.90 million during the quarter, compared to analysts’ expectations of $621.91 million. Teladoc Health had a negative return on equity of 10.13% and a negative net margin of 8.16%.The firm’s revenue for the quarter was down 1.6% compared to the same quarter last year. During the same quarter last year, the business posted ($0.38) EPS. Teladoc Health has set its Q3 2025 guidance at -0.350–0.200 EPS. FY 2025 guidance at -1.350–1.000 EPS. Equities research analysts predict that Teladoc Health, Inc. will post -1.16 earnings per share for the current fiscal year.

Analysts Set New Price Targets

Several equities research analysts have weighed in on TDOC shares. The Goldman Sachs Group dropped their price objective on Teladoc Health from $13.00 to $10.00 and set a “buy” rating for the company in a report on Thursday, May 1st. Bank of America dropped their price objective on Teladoc Health from $8.00 to $7.00 and set a “neutral” rating for the company in a report on Wednesday, May 28th. Stifel Nicolaus dropped their price objective on Teladoc Health from $9.00 to $8.00 and set a “hold” rating for the company in a report on Thursday, May 1st. Canaccord Genuity Group dropped their price objective on Teladoc Health from $14.00 to $12.00 and set a “buy” rating for the company in a report on Thursday, May 1st. Finally, Mizuho started coverage on Teladoc Health in a report on Friday, July 25th. They issued a “neutral” rating and a $10.00 price objective for the company. Six investment analysts have rated the stock with a Buy rating and eleven have issued a Hold rating to the company. According to data from MarketBeat, the company presently has an average rating of “Hold” and a consensus target price of $9.80.

Teladoc Health Profile

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.